Личная информация
- Страна местожительства: Jordan
Информация
Curriculum Vitae
AL-Motassem Fahmi Yousef, PhD
Professor of Pharmacology and Therapeutics
Dean’s Assistant for PharmD Program & Hospital Affairs
Department of Biopharmaceutics and Clinical Pharmacy
College of Pharmacy/Jordan University
Amman, 11942 Jordan
Personal Information
Name:
Al-Motassem Yousef
Current Address:
Department of Biopharmaceutics and Clinical Pharmacy
Faculty of Pharmacy, University of Jordan
Amman, 11942 Jordan
Phone 962-6-488-3837 (home
962-7-77486-930 (cell phone)
962-6-5355000 ext 23357 (work)
email: ayousef72@gmail.com
Web site: http://www2.ju.edu.jo/sites/Academic/ayousef/default.aspx
Education
1988-1989
1989-1995
1997-2002
Ka’ab bin Ady High School, Tawjeehi Certificate (Kuwait) [GPA:97.2%]
Jordan University/College of Pharmacy BSc (Jordan) [GPA:89%]
University of South Carolina/College of Pharmacy PhD (USA) [GPA:3.97] Professional Experience
1995-1997
1997-2002
2002-2008
2009-2012
The University Jordan /College of Pharmacy (Jordan)
Teaching Assistant, industrial pharmacy lab
University of South Carolina/College of Pharmacy (USA)
Teaching Assistant, Hospital Pharmacy, Community Pharmacy
Pharmacist at Palmetto Poison Control Center
The University Jordan /College of Pharmacy (Jordan)
Assistant Professor,
The University Jordan /College of Pharmacy (Jordan)
Applied Science University
Associate Professor,
2013-now
The University Jordan /College of Pharmacy (Jordan)
Professor,
Undergraduate courses
Therapeutics (1, 2, 3, 4), Pharmacology (1, 2), Toxicology, Para-
Pharmaceutics, Over The Counter Drugs, Evidence Based Medicine,
Clinical Pharmacy Practice at JUH Hospital, Pharmaceutical care
Graduate (Master of Clinical Pharmacy)
Therapeutics (1, 2, 3), Research Methodology, Evidence Based
Medicine, General Hospital Training (1, 2), Specialized Hospital
Training.
Languages
Arabic (written and spoken)
English (written and spoken)
Research Interests
I] Pharmacy Care
Development of pharmaceutical care in Jordan
Development of pharmaceutical care education
Rational Use of Drugs
Self medication among Jordanians
Misuse and abuse in community pharmacy
Management gaps in the treatment of chronic diseases (HTN, DM, dyslipidemia and others)
Pharmacokinetics and population pharmacokinetics of antiplatelets (clopidogrel and ticagrelor)
Factors that influence response to antiplatelet agents
II] Molecular pharmacology
Pharmacogenomics of (CYP3A4, CYP3A5, CYP2C19, CYP2C9, CYP2D6, VKORC1, and MDR-1) in relation to pharmacokinetics and pharmacodynamics of tacrolimus, cyclosporine, clopidogrel and warfarin
Cancer pharmacogenomics (Lung cancer, colorectal cancer and breast cancer in relation with methyleneterahydrofolate, thymidylate synthase, and other genes involved in folate pathway)
Pharmacogenetic differences of different ethnicities in Jordan
Pharmacogenomics and susceptibility to diseases
Pharmacogenomics and adverse effects of medicaments References
Professor Tala Abu-Rjai
Professor Enam A. Khalil
Professor Khaled M. Aiedeh
(+962-777424593)
(+962-795737352)
(+962-777424751)
(aburjai@ju.edu.jo) (ekayoub @ju.edu.jo)
(aiedeh@ju.edu.jo)
Prof. Nailia Younes
Prof. Amal G. Al-Bakri
Prof. Yasser K Bustanji
Dr. Mohammad K. Laham
(+962-799377784)
(+962-777970109)
(+962-775620695)
(+962-776717035)
(nyounes@ju.edu.jo)
(agbakri@ju.edu.jo)
(bustanji@ju.edu.jo)
(mklaham1@hotmail.com) Experience
1. Molecular Biology
All aspects of genomics and proteomics
Tissue culture
2. Pharmacy Care
Development and validation of quantitative and qualitative measuring tools Research Funding/Grants
2003
1. Rational drug use in Jordan. (Deanship of Academic Research, University of Jordan, 6, 000 JD).
2006
2. Pharmacogenetics and efficacy of Tacrolimus in Jordanian Kidney transplant patients (Deanship of Academic Research, University of Jordan, 10,000 JD).
2007
3. Genetic Polymorphisms of the CYP3A4 and CYP3A5 Genes and their Impacts on Effectiveness of Tacrolimus among Jordanian Population (Deanship of Academic Research, University of Jordan, 1,500 JD).
2009
4. Influence of genetic polymorphism of ABCB-1 gene at position 3435 on 600mg Clopidogrel Pharmacokinetics as measured by serum level of Carboxylic acid metabolite (Deanship of Academic Research, The University of Jordan, 1, 500 JD).
2010
5. The effect of genetic polymorphism of CYP3A5 on the clopidogrel carboxylate pharmacokinetics, Deanship of Academic Research, University of Jordan. 1,500 JD).
2010
6. The Effect of Genetic Polymorphism of VKORC1 on Warfarin Dose Requirements Among Jordanian Patients at Jordan University Hospital (Deanship of Academic Research, University of Jordan, 1,500 JD).
2011
7. Association between polyadenosine repeats (Poly A) polymorphism at (rs17878969) in 3 untranslated region (3UTR) of the human vitamin D receptors gene (VDR) on susceptibility to asthma among Jordanian. (Deanship of Academic Research, University of Jordan, 1,500 JD)
2012
8. Variability in response to ticagrelor among Jordanian Diabetic and non-Diabetic using ADP as a model agonist (Ex-vivo study). (Deanship of Academic Research, University of Jordan, 2000 JD)
9. Platinum compounds induced-long term hearing impairment and their association with glutathione S- transferase PI (GSTPI) polymorphism at rs1695 among Jordanian people with cancer: case control study. (Deanship of Academic Research, University of Jordan, 1,500 JD)
2012
10. Variability in response to ticagrelor among Jordanian Diabetic and non-Diabetic using ADP as a model agonist (Ex-vivo study). (Deanship of Academic Research, University of Jordan, 2000 JD)
2012
11. Variability in response to Tirofiban among Jordanian Diabetic and non-Diabetic using TRAP as a model agonist (Ex-vivo study). (Deanship of Academic Research, University of Jordan, 2000 JD)
2012
12. The effect of smoking on the variability of aspirin and anti-platelet agent among diabetic patients: an ex vivo study. (Deanship of Academic Research, University of Jordan, 1,500 JD)
2012
13. Appropriateness of the preparation and administration of intravenous medication in the intensive care units at Jordan University Hospital. (Deanship of Academic Research, University of Jordan, 750 JD)
2012
14. How genetic polymorphism of CYP2D6 AND CYP1A2 influnce pharmacokinetics of paroxetine among healthy volunteers? (Deanship of Academic Research, University of Jordan, 21, 000 JD).
2013
15. Allele and genotype frequency of the polymorphic methylenetetrahydrofolate reductase and colorectal cancer among Jordanian population.(Deanship of Academic Research, University of Jordan, 2,000 JD).
2013
16. Allele and genotype frequency of the polymorphic MTHFR & lung cancer among Jordanian population.(Deanship of Academic Research, University of Jordan, 2,000 JD)
2013
17. Impact of smoking on antiplatelet activity of Tyrofiban in Jordanian healthy population using TRAP as an agonist: case controls study. (Deanship of Academic Research, University of Jordan, 1,500 JD)
2013
18. Impact of smoking on antiplatelet activity of Ticagrelor in Jordanian healthy population using ADP as an agonist: case controls study. (Deanship of Academic Research, University of Jordan, 1,500 JD)
2013
19. Appropriateness of the preparation and administration of intravenous medication in the pediatric intensive care unit (ICU) at Palestine medical complex. (Deanship of Academic Research, University of Jordan)
2013
20. Cross sectional evaluation of antibiotic use within the intensive care unit at the University of Jordan hospital. (Deanship of Academic Research, University of Jordan)6
Supervision: M.Sc. Projects
1. Qussa, Hisham. Genetic Polymorphisms Of The CYP3A4 And CYP3A5 Genes And Their Impacts On Effectiveness Of Tacrolimus Among Jordanian Population 2007.
2. Khayyat, Ghada. The Impact Of Donors' Genotype of CYP3A5 on Tacrolimus Pharmacokinetics among Kidney Transplant Patients In Jordanian Population 2008.
3. Manasra, Enas. The effect of genetic polymorphism in the MDR1 gene on the cyclosporine concentration in Jordanian renal transplant patients 2008.
4. Abbadi, Rabee’a.The influence of genetic polymorphism of CYP 3A5 (1*3*6) on Tacrolimus serum concentration among liver transplant 2009.
5. Diab, Ola. Influence of genetic polymorphism of ABCB-1 gene at position 3435 on 600mg Clopidogrel Pharmacokinetics as measured by serum level of Carboxylic acid metabolite 2009
6. Zahran, Farah.The Effect of Genetic Polymorphism of VKORC1 on Warfarin Dose Requirements Among Jordanian Patients at Jordan University Hospital 2010.
7. Zmeili, Rawan. The effect of genetic polymorphism of CYP3A5 on the clopidogrel carboxylate pharmacokinetics 2010.
8. Khirbash, Athar. Influence of genetic polymorphism of MDR1 at position 1236 on 600 mg clopidogrel pharmacokinetics as measured by serum level of carboxylic acid metabolite 2010.
9. Ulemat, Mohammad. Impact of genetic polymorphism of ABCB1 (MDR1) G2677T/A in kidney donors on Tacrolimus level in Jordanian kidney transplant recipients 2010.
10. Borno, Sawsan. Evaluation of factors predictive for quality of coronary artery disease in patients undergoing percutaneous coronary angiography (PCA) 2010.
11. Hasan, Farah. The effect of genetic polymorphism of CYP2C2 at position (430) on warfarin dose requirements among Jordanian patient at JUH 2010.
12. Yusuf, Amina. Genetic polymorphism of vitamin D receptor at RS7975232 and prevalence of asthma among Jordanians: a case-control study 2011.
13. Masaidah, Ahmad. Impact of genetic polymorphism of ABCB1 (MDR1)
2677G>T-A in kidney donors on Tacrolimus level in Jordanian kidney transplant Recipients During The Early Post Transplantation Period 2011.
14. Madhoun, Hussein. Genetic polymorphism of NPPA gene at RS 5065 and prevalence of asthma among Jordanians :case control study 2011.
15. Daghash, Raja’a. Genetic polymorphism of NPPA gene at RS 5065 and prevalence of asthma among Jordanians :case control study 2011.
16. Daqqaq, Ali. Association between the polymorphism of DENND1B gene at rs2786098 on asthma susceptibility among adult Jordanians 2012.
17. Alfayoumi, Moyad. Attention Deficit-Hyperactivity Disorder In School-Aged Children in Jordan, Prevalence and Effect of Clinical Pharmacist On teachers Knowledge RCT 2012 .
18. Abd al-wahab Ghada. Appropriateness of the preparation and administration of intravenous medication in the intensive care units at Jordan University Hospital 2012.
19. Abd al-al Leena. Role of clinical pharmacist's intervention in the management of metabolic manifestations in patients with advanced Chronic Kidney Disease (CKD) 2012.
20. Abu Nema Hanan. Variability of response to ticagrelor among Jordanian Diabetic and non-diabetics using ADP as a model agonist (ex-vivo study). 2013
21. Daghash Ayah. Variability in response to Tirofiban among Jordanian Diabetic and non-diabetics using TRAP as a model agonist (ex-vivo study). 2013
22. Al-Absi Ghadeer. The influence of smoking on the antiplatelet effect of aspirin among diabetics: Case control study. 2013
23. Haddadin Ruba. Cross sectional evaluation of antibiotics use within the intensive care units at the University of Jordan Hospital. 2014
24. Mousa Yousef. Anti-neoplastic Platinium Compounds-induced Ototoxicity and Genetic Polymorphism of GSTP1 among Jordanian Cancer Patients: Case Control Study. 2014
25. Matarneh Mohammad. Variability in Response to Antiplatelet Activity of Ticagrelor among Jordanian Patients with Acute Coronary Syndrome: Cross-Sectional Observational Study. 2014
26. Ala’a Abu Odeh. Genetic polymorphism of TNF alpha and susceptibility to vitiligo, case control study. 2014
27. Khalil Majdalawi. Genetic polymorphism of 6bp deletion/insertion in the 3’UTR of the gene thymidylate synthase and response to 5FU-based chemotherapy in Jordanians with colorectal cancer. 2014
28. Ihab Manasreh. Genetic polymorphism of MTHFR at position 677 and susceptibility of lung cancer among Jordanians: case control study. 2014
29. Weam Qassem. Genetic polymorphism of 6bp deletion/insertion in the 3’UTR of the gene thymidylate synthase and susceptibility of lung cancer among Jordanians: case control study. 2014
30. Ali Abu Halima. Genetic polymorphism MDR1 at 3435 position and susceptibility to breast cancer among Jordanians patients: case control study. 2014. 2015
31. Nemah Awwad. Genetic polymorphism MTHFR at 677 position and susceptibility to breast cancer among Jordanians patients: case control study. 2014. 2015
32. Mohammad Yousef. Genetic polymorphism of 28bp tandem repeats in the 5’UTR of the gene thymidylate synthase and response to 5FU-based chemotherapy in Jordanians with colorectal cancer. 2015
A member in the MSc/PhD examination committees
1. Warfarin dosing and VKORC1 haplotypes in Jordanian patients 2011.
2. Screening for vitamin K epoxide reductase complex 1 (VKORC1) mutation in Jordanian patient with warfarin resistance 2010.
3. Development of novel oral dosage form using cubic liquid crystal delivery system 2000.
4. Management of dyslipedemia in adult diabetic and non diabetic patient in Jordan a study on dyslipidimic patients who attend outpatient clinical at jordan university hospital albasheer hospital and other outpatient clinics 2007.
5. Evaluation of vitamin B12 effects on DNA induced by pioglitazone 2011.
6. The impact of patient education about warfarin on improvement of their basal knowledge regarding its administration and side effects a study on patient who receive warfarin at Jordan university hospital 2007.
Conferences and Talks Attended
1. The 1st conference held by Scientific Research Organization in Jordan. (2003). Amman, Jordan.
2. The 3rd International Conference of the Royal Medical Services in Collaboration with the Royal College of Physicians of London (April 5th- 8th, 2006). Amman, Jordan.
3. The 4th International Conference of the Royal Medical Services (2008).
Amman, Jordan.
4. The 1st Scientific Day of the American Association for Cancer Research (2008). Dead Sea, Jordan.
5. The 5th International Conference of the Royal Medical Services (2010). Dead Sea, Jordan.
6. The 2nd Scientific Day of School of Pharmacy at Isra’a Private University. The role of Clinical Pharmacist in Health Awareness and quality Control (May, 2010). Amman, Jordan.
7. Workshop in Clinical Pharmacy, Jordanian Pharmaceutical Association (December, 2011) Amman, Jordan.
8. Scientific Day conference of School of Pharmacy and Medical Sciences at Petra Private University. Pharmacy Profession, Challenges and Ethics (June, 2012) Amman, Jordan.
9. The 3rd International Scientific Conference of School of Pharmacy at University of Jordan. Recent Developments in Pharmacy Profession (Oct, 2012). Amman Jordan.
10. The 6th International Conference of the Royal Medical Services (2012). Dead Sea, Jordan.
11. First scientific day of School of Pharmacy at Zarqa Private University. Pharmacy and Future Perspectives (May, 2013) Zarqa-Jordan.
12. Sixth scientific day of School of Pharmacy at Jordan University for Science and Technology. Clinical Pharmacy Education in Jordan. (April, 2013) Irbid, Jordan. 13. The 9th international conference of oncology medicine.
14. The 2nd conference on advance in critical care medicine. King Hussein Cancer Center in collaboration with Middle East Society of Critical Care Medicine. October 21st-23rd at Le Royal, Amman, Jordan. Conferences: Poster Presentations
1. Bustanji Y, Taha M, Yousef AM, Al- Bakri A. Berberine Potently Inhibits Protein Tyrosine Phosphatase 1B: Investigation by Docking Simulation and Experimental Validation. The 9th International Pharmaceutical Sciences Conference and Exposition (December 17th -21st, 2005) Riyadh, Saudi Arabia.
2. Al- Bakri A, Bustanji Y, Yousef AM. Community antibacterial consumption in Jordan: Prudent use or Misuse and Abuse. 4th Arab Symposium for Antimicrobial Agents (April 2006). Tunis.
3. Yousef AM, Bulatova N, Al-Sous M. The Value of Education in the Management of Warfarin Therapy. The 11th Scientific Congress of the Association of the Colleges of Pharmacy in the Arab World (December 7th – 12th, 2007). Tripoli, Libya.
4. AbuRuz S, Bulatova N, Yousef AM, Al-Gazawi MA. Comprehensive prospective assessment for treatment related problems in hospitalized internal medicine patients. The 16th International Social Pharmacy Workshop conference (August 2010). Lisbon, Spain
5. Luo B, Repalli J, Yousef AM, Johnson SR, Lebioda L, Berger SH. Human thymidylate synthase with loop 181-197 stabilized in an inactive conformation: ligand interactions, phosphorylation, and inhibition profiles. The 3rd International Scientific Conference of School of Pharmacy at University of Jordan (October 9th -11th 2012). Amman, Jordan.
6. Amrani I, Bulatova N, Abbadi AA, Massad J, Yousef AM, Al-Masri M, Abu Tahoun L. Association between M2 polymorphism in CYPA1 and breast carcinoma among Jordanian women: a case control study. The 3rd International Scientific Conference of School of Pharmacy at University of Jordan (October 9th -11th 2012). Amman, Jordan.
7. Yusuf A, Yousef AM. Genetic polymorphism of vitamin D receptor at RS7975232 and prevalence of asthma among Jordanians: a case-control study. The 3rd International Scientific Conference of School of Pharmacy at University of Jordan (October 9th -11th 2012). Amman, Jordan.
Conference Podium Presentations
1. Yousef AM, Al- Bakri A, Bustanji Y, Wazyfi Y, Self-medication patterns in Amman, Jordan. The First Scientific Conference on OTC Use and Abuse in Jordan organized by Jordan Pharmacy Association (December 2006). Amman, Jordan.
2. Bustanji Y, Taha M, Yousef AM, Al- Bakri A. Protein Tyrosine Phosphatase 1B Inhibitors as Potential New Hypoglycemic Agents. The 3rd International conference of the Royal Jordanian Medical Services (April 5th- 8th, 2006), Amman, Jordan.
3. Al- Bakri A, Bustanji Y, Yousef AM. Antibacterial Drug Consumption among Jordanian Population: Current Situation and Future Plans. The 3rd International conference of the Royal Jordanian Medical Services (April 5th- 8th, 2006), Amman, Jordan.
4. Yousef AM, Bulatova N, Al-Sous M. The Value of Education in the Management of Warfarin Therapy. The 26th Congress of The Union of the Arab Pharmacists and The 12th Jordanian Scientific Pharmaceutical Congress, (April 10th – 12th , 2008), Amman, Jordan.
5. Yousef AM. Pharmacogenomic of cyclosporin & tacrolimus. the second sentific day of Zarqa Privet University, Genomics pharmacogenomics, proteomics & Bioinformatics, (May 4th, 2008), Amman, Jordan.
6. Yousef AM .The value of education in the management of warfarin therapy: prospective interventional study. The 5th Palestinain pharmaceutical and first clinical pharmacy conference. (2009), Ramallah- Palestine.
7. Yousef AM , Aburuz S, Bulatova N, Bashiti I, Al-Qunybi I, Al-Saleh S. Clincial pharmayc and pharmaceutical care where are we standing? experience at Jordan Unoversity Hospital and Inb Al-Hytham Hospital. The 6th Palestinain pharmaceutical and second clinical pharmacy conference. (2009), Bait Lahem- Palestine.
8. Dyab O, Yousef AM, Arafat T, Younes N. Pharmqacogenomics and clopidogrel pharmacokinetics. The 6th Paletinain pharmaceutical and second clinical pharmacy conference. (2009), Bait Lahem- Palestine.
9. Yousef AM, Zahran F, Al-Salehm A, Obeidat N, Sanady M. The effect of genetic polymorphism of VKORC1 on Warfarin Dose Requirmants among Jordanian Patients. The 6th Palestinain pharmaceutical and second clinical pharmacy conference. (2009), Bait Lahem- Palestine.
10. Yousef AM .Drug –Drug interaction. Eli illy work shop in clinical pharmacy.(2009), Amman, Jordan.
11. Aburuz S, Bulatova N, Yousef AM, Ghazawi M. Comprehensive prospective assessment for treatment related problems in hospital internal medicine patients.
The 16th ISPW (International Pharmacy Social Workshop) scientific conference (23rd to 26th August 2010), Lisbon, Spain.
12. Yousef AM , Bashiti I, Qunybi I, Al-Saleh S. Clincial pharmayc and pharmaceutical care where are we standing? Experience at Ibn Al-Hythem Hospital. The 13th Pharmaceutical Conference of Jordan Pharmaceutical Association, (2010). Amman, Jordan.
13. Bulatova N, Yousef AM, Al-Khayyat G, Qosa. H Adverse Effects of Tacrolimus in Renal Transplant Patients from Living Donors. The 3rd Kuwait International Pharmacy Conference, (February 2011). Kuwait, Kuwait.
14. Yousef AM. Drug exposure in preganacy. The 1st Jordan Pharmaceutical Association Symposium in Zarqa, (2011), Zarqa, Jordan.
15. Yousef AM. Pharmacokinetic of proton pump inhibitors how best applied clinically in individual patient level. Standalone symposium in the management on GERD disorders. (2011), Czech Republic.
16. Xue B, Melhem M, Reynold D, Yousef AM, Van Wart S. Population pharmacokinetic analysis and design on optimum sampling strategy of clopidogrel. American Conference on Pharmacometrics, (2011) USA.
17. Yousef AM .Patient counseling. Jordan Pharmaceutical Association Workshop of Clinical Pharmacy, (2011). Amman, Jordan.
Workshops and Training Courses Attended
1. Teaching and Assessment Methods. Centre for Educational Development. (2nd Dec. - 24th of Jan. 2003). Amman, Jordan.
2. Managing Multiple Choice Questions. Centre for Educational Development. (3rd June, 2003). Amman, Jordan.
3. Training course on using Blackboard. King Abdulla II School for Information and Technology (2005). Amman, Jordan.
4. Curriculum Development. School of Medicine (15th to 20th of Feb. 2003). Amman, Jordan.
5. Coordination of workshop on the rehabilitation of addict in collaboration with the National Center for the Rehabilitation of Addict (24th of May, 2003). Amman, Jordan.
6. Work shop on the intellectual property in the Science Institute for Intellectual Property Services, (2003). Amman, Jordan. Memberships 1995-current Jordan Pharmaceutical Association, Jordan. 2008-2011 2011-2013 2011-now 2013-now Member of Committee on Re-registration of generics at Jordan FDA Member of Higher Committee on Registration of Generics at JFDA Member of Committee on Pharmacovigilance at Jordan FDA Member of Higher Committee on Registration of Originators at JFDA 2002-current Member at a number of University and Faculty committees, Scientific research committee, Library committee, Equipment and laboratory committee, Safety committee, Students disciplinary actions committee, School of pharmacy board, curriculum committee, pharmacy care unit Tempus). 2011-2012 2012-now Department representative at the Faculty council. Member of Faculty Council as the Dean’s Assistant Computer Skills and Others 1. The University of Jordan Computer Driving License (UJCDL), passing successfully of 7 of its modules. (Introduction, Windows, Word, Excel, PowerPoint, Access, Internet). 2. Statistical Package for the Social Sciences
Referee for manuscript published within 1. Jordan Journal of Pharmaceutical Sciences 2. Journal of Complementary and Alternative Medicine 3. Molecular biology reports 4. International journal of clinical pharmacy 5. International journal of cardiology Teaching Experience 1. Undergraduate Pharmacy and PharmD students: Pharmacology 1, Pharmacology 2, Pharmacotherapy 1, Pathophysiology, Pharmacotherapy 2, Pharmacotherapy 3, Pharmacotherapy 4, Non-prescription Drugs, Clinical Pharmacy Practical Course at Jordan University Hospital, Training in Clinical Pharmacy (Internal Medicine, Out-patient and Gynecology), Research methodology, Evidence based medicine, Toxicology, Parapharmaceutics. 2. Master in Clinical Pharmacy: Pharmacotherapy 1, Pharmacotherapy 2, Pharmacotherapy 3, Clinical Pharmacy Training 1, Clinical Pharmacy Training 2, Clinical Pharmacy Training 3 (Specialized), Pharmaceutical Care, Research methodology, Evidence based medicine, Biotechnology.
Достижения и награды
1. King Abdullah II Design and Development fund for best research of the year, 2013.
Publications
1. Yousef AM, Davis RA, Sticca RP, Berger SH. Structural analysis of cDNA encoding thymidylate synthesis in hepatic metastases of human colorectal tumors. International Journal of Colorectal Disease. 2001 Sep; 16(5): 318-25.
2. Al-Bakri AG, Bustanji Y, Yousef AM. Community consumption of antibacterial drugs within the Jordanian population: sources, patterns and appropriateness. International Journal of Antimicrobial Agents. 2005 Nov; 26(5):389-95.
3. Brittnaie J Bell, AM Yousef, Lukasz Lebioda, Sondra Berger. Effects of serine substitution on the function and structure of human thymidylate synthase. Proceedings of the American Association for Cancer Research 2005: 979
4. Bustangi Y, Taha M, Yousef AM, Bakri AG. Berberine potently inhibits protein tyrosine phosphatase 1B: investigation by docking simulation and experimental validation. Journal of Enzyme Inhibition and Medicinal chemistry. 2006 Apr;21(2):163-71.
5. Aburuz S, Bulatova NR, Yousef AM. Validation of comprehensive treatment related problems assessment and classification tool. Pharmacy World and Science. 2006 Aug; 28(4):222-32. Epub 2006 Oct 26.
6. Bulatova NR, Yousef AM, Aburuz SM. Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitus. Thrombosis Research. 2007; 121(1):43-50. Epub 2007 Apr 25.
7. Bulatova NR, Aburuz S, Yousef AM. An Innovative Pharmaceutical Care Practical Course. Advanced of Health Science Education Theory Practice. 2007 May; 12(2):211-22. Epub 2006 Oct 14.
8. Taha MO, Bustanji Y, Al-Bakri AG, Yousef AM, Zalloum WA, Al-Masri IM, Atallah N. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening. Journal of Molecular Graphical Model. 2007 Mar;25(6):870-84. Epub 2006 Sep 3.
9. Yousef AM, Bulatova N, AbuRuz S. Management of Coronary Artery Disease in Jordan? Cross-Sectional Comparative Study. Jordan Journal of Pharmaceutical Sciences. 2008 Jan; 1(1): 28-39.
10. Yousef AM, Al-Bakri AG, Bustanji Y, Wazaify M. Self-medication
- key_active_year
: key_active_from
key_active_to